LTFS
CYTK icon

Ladenburg Thalmann Financial Services’s Cytokinetics CYTK Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$18K Sell
1,666
-1,000
-38% -$10.3K ﹤0.01% 4197
2019
Q3 		$31K Hold
2,666
– – ﹤0.01% 3750
2019
Q2 		$30K Sell
2,666
-7,000
-72% -$67.5K ﹤0.01% 3797
2019
Q1 		$79K Hold
9,666
– – ﹤0.01% 3055
2018
Q4 		$62K Sell
9,666
-51
-0.5% -$374 ﹤0.01% 3109
2018
Q3 		$95K Buy
9,717
+5,736
+144% +$46K ﹤0.01% 2864
2018
Q2 		$28K Hold
3,981
– – ﹤0.01% 3632
2018
Q1 		$28K Buy
3,981
+40
+1% +$343 ﹤0.01% 3632
2017
Q4 		$32K Buy
3,941
+23
+0.6% +$261 ﹤0.01% 3505
2017
Q3 		$57K Buy
3,918
+818
+26% +$11.2K ﹤0.01% 2989
2017
Q2 		$37K Hold
3,100
– – ﹤0.01% 3216
2017
Q1 		$40K Buy
3,100
+1,100
+55% +$12.9K ﹤0.01% 3073
2016
Q4 		$24K Hold
2,000
– – ﹤0.01% 3364
2016
Q3 		$18K Sell
2,000
-45
-2% -$470 ﹤0.01% 3463
2016
Q2 		$19K Sell
2,045
-3,090
-60% -$25.4K ﹤0.01% 3363
2016
Q1 		$36K Buy
5,135
+3,275
+176% +$23.9K ﹤0.01% 2836
2015
Q4 		$19K Buy
+1,860
New +$18.2K ﹤0.01% 3263
2014
Q1 		– Sell
-166
Closed -$1K – 3772
2013
Q4 		$1K Hold
166
– – ﹤0.01% 3612
2013
Q3 		$1K Buy
+166
New +$1.78K ﹤0.01% 3549

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ladenburg Thalmann Financial Services's CYTK Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Cytokinetics (CYTK) stake by 38% in Q4 2019, selling an estimated $10.3K and leaving 1,666 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #4197.

Ladenburg Thalmann Financial Services first reported a position in CYTK in Q3 2013 and has held it in 19 quarters since. The position peaked at $95K in Q3 2018. 142 funds tracked by Wall St. Rank hold CYTK as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,666 shares of Cytokinetics worth $18K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 1,000 Cytokinetics shares in Q4 2019, an estimated $10.3K.
  • Cytokinetics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4197 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Cytokinetics in Q3 2013 and has held it in 19 quarters since.
  • Ladenburg Thalmann Financial Services's Cytokinetics position peaked at $95K in Q3 2018.
  • 142 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.